US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist
  • 17.320
  • -0.590-3.29%
Close Dec 13 16:00 ET
  • 17.320
  • 0.0000.00%
Post 16:15 ET
1.51BMarket Cap-3.78P/E (TTM)

About Travere Therapeutic Company

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Company Profile

SymbolTVTX
Company NameTravere Therapeutic
Listing DateJan 10, 2014
Founded2008
CEODr. Eric M. Dube, PhD
MarketNASDAQ
Employees380
Fiscal Year Ends12-31
Address3611 Valley Centre Drive,Suite 300
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-888-969-7879

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Eric M. Dube, PhD
  • Director, President and Chief Executive Officer
  • 7.57M
  • Dr. Jula Inrig
  • Chief Medical Officer
  • --
  • Peter Heerma
  • Chief Commercial Officer
  • 2.00M
  • Sandra Calvin
  • Senior Vice President and Chief Accounting Officer
  • --
  • Christopher Cline
  • Chief Financial Officer
  • 1.97M
  • Elizabeth E. Reed
  • Senior Vice President, General Counsel and Corporate Secretary
  • 2.02M
  • William E. Rote
  • Senior Vice President, Research and Development
  • 2.05M
  • Gary A. Lyons
  • Chairman of the Board
  • 392.98K
  • Sandra E. Poole
  • Independent Director
  • 369.86K
  • John A. Orwin
  • Independent Director
  • 372.98K
  • Ruth WilliaBrinkley
  • Independent Director
  • 365.48K
  • Jeffrey A. Meckler
  • Independent Director
  • 379.98K
  • Dr. Suzanne L. Bruhn, PhD
  • Independent Director
  • 372.36K
  • Timothy P. Coughlin
  • Independent Director
  • 385.48K
  • Ron Squarer
  • Independent Director
  • 367.98K
  • Dr. Roy D. Baynes, M.D.,PhD
  • Independent Director
  • 376.73K
Heat List
US
Overall
Symbol
Price
% Chg

No Data